Literature DB >> 9500681

Remission and residual symptomatology in major depression.

E S Paykel1.   

Abstract

This paper reports the course of remission of 64 major depressives, predominantly inpatients, whose course was followed longitudinally with repeated assessment. Remission was comparatively rapid for many of the subjects so that 70% had remitted by 6 months. Only 6% failed to remit by 15 months. Slower remission occurred in those subjects who were initially more severely ill and had longer episodes. Detailed examination at the time of remission revealed that residual symptoms reaching 8 or more on the Hamilton Depression Scale were present in 32% of subjects who remitted below major depression. The pattern was of mild typical depressive symptoms without major biological symptoms. Residual symptoms were more common in subjects with more severe initial depression, but were unrelated to other predictors including longer prior illness, dysthymia or lower dose of drug treatment during the index episode. There were weak associations with passive dependent personality traits, which might however have been reflections of persisting symptom presence. Neither remission nor residual symptoms were related to life stress. Residual symptoms were strong predictors of subsequent relapse. Residual symptoms comprise an important adverse outcome in depression which is common and has received comparatively little attention in the past.

Entities:  

Mesh:

Year:  1998        PMID: 9500681     DOI: 10.1159/000029018

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  24 in total

Review 1.  Fortnightly review: drug treatment of depression.

Authors:  O Spigset; B Mårtensson
Journal:  BMJ       Date:  1999-05-01

2.  Medicine Cabinet: Drug treatment of depression.

Authors:  B Martensson; O Spigset
Journal:  West J Med       Date:  1999-08

3.  Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.

Authors:  Roger S McIntyre; Jakub Z Konarski; Deborah A Mancini; Kari A Fulton; Sagar V Parikh; Sophie Grigoriadis; Larry A Grupp; David Bakish; Marie-Josee Filteau; Chris Gorman; Charles B Nemeroff; Sidney H Kennedy
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

4.  What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Authors:  Rebecca Schennach; Michael Riedel; Michael Obermeier; Ilja Spellmann; Richard Musil; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

5.  Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.

Authors:  Shawn M McClintock; Mustafa M Husain; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Madhukar H Trivedi; Ian Cook; David Morris; Diane Warden; Augustus John Rush
Journal:  J Clin Psychopharmacol       Date:  2011-04       Impact factor: 3.153

Review 6.  Evidence for the management of adolescent depression.

Authors:  R Eric Lewandowski; Mary C Acri; Kimberly E Hoagwood; Mark Olfson; Greg Clarke; William Gardner; Sarah Hudson Scholle; Sepheen Byron; Kelly Kelleher; Harold A Pincus; Samantha Frank; Sarah M Horwitz
Journal:  Pediatrics       Date:  2013-09-16       Impact factor: 7.124

Review 7.  Pharmacotherapy to sustain the fully remitted state.

Authors:  Sidney Kennedy; Roger McIntyre; Angelo Fallu; Raymond Lam
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

8.  Adapted behavior therapy for persistently depressed primary care patients: an open trial.

Authors:  Lisa A Uebelacker; Risa B Weisberg; Ryan Haggarty; Ivan W Miller
Journal:  Behav Modif       Date:  2009-03-11

9.  A 4-year follow-up study of syndromal and sub-syndromal anxiety and depression symptoms in the general population: the HUNT study.

Authors:  Ottar Bjerkeset; Hans M Nordahl; Sara Larsson; Alv A Dahl; Olav Linaker
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-12-06       Impact factor: 4.328

10.  Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy.

Authors:  Richard C. Shelton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.